Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0 | 0 | ||||||||
| Gross profit | 0 | 0 | ||||||||
| Operating expense | -28.46%608.68K | -8.35%595.45K | -20.89%582K | -70.40%2.86M | -29.44%622.93K | -64.59%850.76K | -83.96%649.66K | -68.37%735.66K | -42.12%9.66M | -22.38%882.89K |
| Selling and administrative expenses | -56.47%252.98K | -22.23%305.45K | -9.17%276.58K | -18.03%1.63M | 58.14%396.73K | 83.10%581.23K | -62.92%392.77K | -14.30%304.52K | -52.43%1.98M | -40.59%250.87K |
| -General and administrative expense | -56.47%252.98K | -22.23%305.45K | -9.17%276.58K | -18.03%1.63M | 58.14%396.73K | 83.10%581.23K | -62.92%392.77K | -14.30%304.52K | -52.43%1.98M | -40.59%250.87K |
| Research and development costs | -97.49%790 | 236.74%29.12K | 26.32%72.05K | -46.95%147.35K | -99.63%208 | -62.32%31.45K | -90.52%8.65K | 20.13%57.04K | -39.80%277.74K | -8.27%55.57K |
| Other operating expenses | 49.07%354.91K | 5.09%260.88K | -37.62%233.36K | -85.32%1.09M | -60.79%226K | -88.11%238.09K | -91.44%248.25K | -80.54%374.1K | -38.64%7.4M | -11.94%576.44K |
| Operating profit | 28.46%-608.68K | 8.35%-595.45K | 20.89%-582K | 70.40%-2.86M | 29.44%-622.93K | 64.59%-850.76K | 83.96%-649.66K | 68.37%-735.66K | 42.17%-9.66M | 22.38%-882.89K |
| Net non-operating interest income (expenses) | 20.48%-47.71K | -242.92%-46.15K | -47.71K | -146.91K | -73.46K | -60K | -13.46K | 0 | 0 | 0 |
| Non-operating interest income | --0 | --0 | ---- | ---- | ---- | --0 | --89 | ---- | ---- | ---- |
| Non-operating interest expense | -20.48%47.71K | 240.67%46.15K | --47.71K | --146.91K | --73.37K | --60K | --13.55K | --0 | --0 | --0 |
| Other net income (expenses) | 43.53%-16.15K | 36.04%-28.73K | -117.11%-10.85K | -98.93%51.41K | 169.29%61.53K | -263.27%-28.6K | -366.38%-44.93K | -98.70%63.41K | 5,771.04%4.79M | -106.31%-88.8K |
| Gain on sale of security | 43.53%-16.15K | 36.04%-28.73K | -117.11%-10.85K | 69.43%-28.02K | 79.84%-17.9K | -263.27%-28.6K | -366.38%-44.93K | 690.12%63.41K | -8.56%-91.66K | -106.31%-88.8K |
| Special income (charges) | ---- | ---- | ---- | -98.37%79.43K | --79.43K | --0 | --0 | ---- | --4.88M | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---79.43K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | --4.88M | --0 |
| Income before tax | 28.40%-672.54K | 5.33%-670.33K | 4.71%-640.55K | 39.36%-2.95M | 34.66%-634.86K | 60.62%-939.37K | 82.56%-708.05K | -126.43%-672.25K | 70.97%-4.87M | 17.69%-971.69K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 28.40%-672.54K | 5.33%-670.33K | 4.71%-640.55K | 39.36%-2.95M | 34.66%-634.86K | 60.62%-939.37K | 82.56%-708.05K | -126.43%-672.25K | 70.97%-4.87M | 17.69%-971.69K |
| Net income continuous operations | 28.40%-672.54K | 5.33%-670.33K | 4.71%-640.55K | 39.36%-2.95M | 34.66%-634.86K | 60.62%-939.37K | 82.56%-708.05K | -126.43%-672.25K | 70.97%-4.87M | 17.69%-971.69K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 28.40%-672.54K | 5.33%-670.33K | 4.71%-640.55K | 39.36%-2.95M | 34.66%-634.86K | 60.62%-939.37K | 82.56%-708.05K | -126.43%-672.25K | 70.97%-4.87M | 17.69%-971.69K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 28.40%-672.54K | 5.33%-670.33K | 4.71%-640.55K | 39.36%-2.95M | 34.66%-634.86K | 60.62%-939.37K | 82.56%-708.05K | -126.43%-672.25K | 70.97%-4.87M | 17.69%-971.69K |
| Diluted earnings per share | 0.00%-0.002 | 0.00%-0.002 | 0.00%-0.002 | 46.15%-0.007 | 66.67%-0.001 | 66.67%-0.002 | 81.82%-0.002 | -128.57%-0.002 | 71.11%-0.013 | 0.00%-0.003 |
| Basic earnings per share | 0.00%-0.002 | 0.00%-0.002 | 0.00%-0.002 | 46.15%-0.007 | 66.67%-0.001 | 66.67%-0.002 | 81.82%-0.002 | -128.57%-0.002 | 71.11%-0.013 | 0.00%-0.003 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.